Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-22

FDA Approved: CLOBAZAM — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals' original ANDA for CLOBAZAM (clobazam), enabling the generic version of the epilepsy medication to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

ORIG AP for CLOBAZAM (CLOBAZAM)